On Capitol Hill, PBM Execs Deny Role In High Drug Costs
By Mark Payne
July 23, 2024
Executives from the nation’s three largest pharmacy benefit managers told members of a U.S. House committee on Tuesday that they lower drug costs while pointing the finger at pharmaceutical manufacturers.
Click here to read the original article.
